53 results
8-K
EX-4.1
AQST
Aquestive Therapeutics Inc
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
of such employee’s termination, death or disability; provided, further, that any class of Capital Stock of such Person that by its terms authorizes … course of business, including letters of credit in respect of workers’ compensation claims, health, disability or other benefits to employees or former
S-8
EX-4.1
AQST
Aquestive Therapeutics Inc
9 Aug 23
Registration of securities for employees
5:22pm
that directly or indirectly promote or maintain a market for the Company’s Shares or other securities.
2.10. “Disability” means,
(a) if the applicable … is defined therein, “Disability” shall have the meaning provided in such agreement;
(b) if the applicable Participant is not a party to an effective
PRE 14A
AQST
Aquestive Therapeutics Inc
18 Apr 23
Preliminary proxy
8:50am
and disability benefits to our executive officers.
We maintain a 401(k) retirement savings plan that provides eligible U.S. colleagues … the following:
Mr. Barber
Ms. Braender
Mr. Schobel
Mr. Kendall
401(k) Company match
Disability insurance premiums
Life insurance premiums
Severance
8-K
EX-99.1
8gg fjw7tay
10 Aug 22
Unregistered Sales of Equity Securities
5:15pm
8-K
f08o078fnrd3prtw6
19 Jul 22
Departure of Directors or Certain Officers
4:46pm
8-K
h2rq7er
21 Jun 21
Departure of Directors or Certain Officers
11:15am
8-K
EX-4.1
2ooh8k3vj7degmaj
16 Jul 19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
12:00am
DEF 14A
li0uh9ab
26 Apr 19
Definitive proxy
11:18am
10-K
o6dl6m488i69acue
14 Mar 19
Annual report
2:04pm
8-K
EX-99.2
duah2ne
6 Nov 18
Aquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights
4:28pm
424B4
vt45gxx
26 Jul 18
Prospectus supplement with pricing info
4:52pm